Drugs / TWP-201
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04878705 | May 2021 → Oct 2022 | infertility disorder | Shandong TheraWisdom Biopharma Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TWP-201 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04878705 ↗ |
| Modality | Protein / enzyme biologic | “recombinant human follicle stimulating hormone Fc fusion protein injection (TWP-201)” NCT04878705 ↗ |
| Route | Subcutaneous | “a single subcutaneous injection” NCT04878705 ↗ |